Noble Laureate in Medicine (1998) Prof. Dr Ferid M (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.
In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Treating cancer with longevity promoting drugs: Resveratrol, a longevity promoting small molecule, suppresses the expression of NOS2 via up regulation of its target gene. This study provides mechanistic insights into how Resveratrol inhibits the expression of NOS-2.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
To cite: Boominathan, Treating cancer with longevity promoting drugs: Resveratrol, a longevity promoting small molecule, suppresses the expression of NOS2 via up regulation of its target gene, 13/March/2014, 11.55, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
